DOI: 10.1055/s-00000062

Psychiatrische Praxis

Referenz

Schmidt-Kraepelin C, Feyerabend S, Engelke C. et al.
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.

Eur Arch Psychiatry Clin Neurosci 2019;
DOI: 10.1007/s00406-019-01063-4.

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: